{"data":[{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Logos Global Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":10538440,"percentOfClass":9.99,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Arsani William","reportingCik":null,"personType":"HC,IN","sharesOwned":10538440,"percentOfClass":9.99,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Logos Global Management GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":10538440,"percentOfClass":9.99,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Logos Global Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":5200000,"percentOfClass":5.1,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Logos GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5200000,"percentOfClass":5.1,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Logos Opportunities Fund V LP","reportingCik":null,"personType":"PN","sharesOwned":5338440,"percentOfClass":5,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Logos Opportunities V GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":5338440,"percentOfClass":5,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000935836-26-000426","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-05-11","reportingPerson":"Graham Walmsley","reportingCik":null,"personType":"HC,IN","sharesOwned":5338440,"percentOfClass":5,"filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001274173-26-000193","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":5502064,"percentOfClass":5.4,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000201","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Franklin Advisers, Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":8878942,"percentOfClass":8.3,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000201","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Franklin Resources, Inc.","reportingCik":null,"personType":"HC,CO","sharesOwned":8878942,"percentOfClass":8.3,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000201","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Charles B. Johnson","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000201","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Rupert H. Johnson, Jr.","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0002012383-26-002256","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES INC","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":5271391,"percentOfClass":5.1,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001213900-26-076390","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-06","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":5305640,"percentOfClass":5,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001213900-26-076390","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-06","reportingPerson":"Vivo Opportunity Co-Invest (Cycle 3), L.P.","reportingCik":null,"personType":"PN","sharesOwned":2140852,"percentOfClass":2,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001213900-26-076390","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-06","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1944430,"percentOfClass":1.8,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001213900-26-076390","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-06","reportingPerson":"Vivo Opportunity Co-Invest, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1220358,"percentOfClass":1.2,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001213900-26-076390","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-06","reportingPerson":"Vivo Opportunity Cayman, LLC","reportingCik":null,"personType":"OO","sharesOwned":196424,"percentOfClass":0.2,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001213900-26-076390","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-06","reportingPerson":"Vivo Opportunity Cayman Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":196424,"percentOfClass":0.2,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000122","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-30","reportingPerson":"Franklin Resources, Inc.","reportingCik":null,"personType":"HC,CO","sharesOwned":6369252,"percentOfClass":6.2,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000122","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-30","reportingPerson":"Franklin Advisers, Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":6369252,"percentOfClass":6.2,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000122","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-30","reportingPerson":"Charles B. Johnson","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000122","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-30","reportingPerson":"Rupert H. Johnson, Jr.","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000905148-26-001871","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-15","reportingPerson":"venBio Global Strategic GP V, LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":10737317,"percentOfClass":9.99,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000905148-26-001871","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-15","reportingPerson":"venBio Global Strategic Fund V, L.P.","reportingCik":"0002029777","personType":"PN","sharesOwned":10737317,"percentOfClass":9.99,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001999371-26-009036","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-04-17","reportingPerson":"James G. Coulter","reportingCik":"0001099776","personType":"IN","sharesOwned":13755160,"percentOfClass":12.6,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001999371-26-009036","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-04-17","reportingPerson":"Jon Winkelried","reportingCik":"0001366946","personType":"IN","sharesOwned":13755160,"percentOfClass":12.6,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001999371-26-009036","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-04-17","reportingPerson":"TPG GP A, LLC","reportingCik":"0001903793","personType":"OO","sharesOwned":13755160,"percentOfClass":12.6,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001104659-26-048793","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-04-17","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":9903712,"percentOfClass":9.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001104659-26-048793","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-04-17","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":9903712,"percentOfClass":9.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001104659-26-048793","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-04-17","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":9903712,"percentOfClass":9.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001104659-26-048793","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-04-17","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":8687536,"percentOfClass":8.1,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6625788,"percentOfClass":6.5,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"FHMLSP, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":6625788,"percentOfClass":6.5,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"FHMLSP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6625788,"percentOfClass":6.5,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001738048-26-000040","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":5502064,"percentOfClass":5.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001738048-26-000040","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":5502064,"percentOfClass":5.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001738048-26-000040","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":5502064,"percentOfClass":5.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001738048-26-000040","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":5502064,"percentOfClass":5.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001738048-26-000040","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5502064,"percentOfClass":5.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001738048-26-000040","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":5502064,"percentOfClass":5.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001738048-26-000040","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5502064,"percentOfClass":5.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"FHMLS XII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":777090,"percentOfClass":0.8,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"FHMLS XII, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":777090,"percentOfClass":0.8,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"Frazier Life Sciences XII, L.P.","reportingCik":null,"personType":"PN","sharesOwned":777090,"percentOfClass":0.8,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":61958,"percentOfClass":0.1,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"FHMLS XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":61958,"percentOfClass":0.1,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001231919-26-000406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":"004468500","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-17","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":61958,"percentOfClass":0.1,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000017","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Franklin Resources, Inc.","reportingCik":null,"personType":"HC,CO","sharesOwned":6369193,"percentOfClass":11.5,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000017","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Franklin Advisers, Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":6369193,"percentOfClass":11.5,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000017","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Charles B. Johnson","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0000038777-26-000017","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Rupert H. Johnson, Jr.","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001172661-25-005187","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":2982722,"percentOfClass":5.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001172661-25-005187","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":2982722,"percentOfClass":5.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001172661-25-005187","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000949858","issuerName":"Achieve Life Sciences, Inc.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":2982722,"percentOfClass":5.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001013594-25-001417","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Parker Quillen","reportingCik":null,"personType":"IN","sharesOwned":2528377,"percentOfClass":4.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001013594-25-001417","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Contrarian Achieve SPV, LP","reportingCik":null,"personType":"PN","sharesOwned":1978377,"percentOfClass":3.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001013594-25-001417","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Contrarian Achieve GP LLC","reportingCik":null,"personType":"IA","sharesOwned":1978377,"percentOfClass":3.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001013594-25-001417","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Contrarian Alpha GP, LLC","reportingCik":null,"personType":"IA","sharesOwned":550000,"percentOfClass":1.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001013594-25-001417","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Contrarian Alpha Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":550000,"percentOfClass":1.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"},{"accessionNo":"0001013594-25-001417","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000949858","issuerName":"ACHIEVE LIFE SCIENCES, INC.","ticker":"ACHV","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Contrarian Alpha, LP","reportingCik":null,"personType":"PN","sharesOwned":550000,"percentOfClass":1.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/achv"}],"updatedAt":"2026-11-05T13:13:55.776Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/achv","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}